Baraclude 0.05 mg/mL, Lösung zum Einnehmen

7680574360019 CH-57436 Lösung
Baraclude 0.05 mg/mL, Lösung zum Einnehmen
Baraclude 0.05 mg/mL, Lösung zum Einnehmen
Baraclude 0.05 mg/mL, Lösung zum Einnehmen
1 / 3
google

Article details

Package size
210
Selling units
210
Measure
ml
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
0.05 MG Substance Wirkstoff (Principe actif)
(N/A)
380.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
180.0 UG Substance HBESI
(N/A)
1.5 MG Substance HBESI
(N/A)
0.3 MG Substance HBESI

Authorization holder

Bristol-Myers Squibb SA

6312 Steinhausen

Authorization information

Swissmedic authorization number
57436
Drug name
Baraclude 0.05 mg/mL, Lösung zum Einnehmen
Galenic form
LSOR
ATC Code
J05AF10
Authorization status
Z
Dispensing category
A
First authorization
10/08/2006
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Chronische Hepatitis B

Package details

Description (FR)
BARACLUDE sol 0.05 mg/ml fl 210 ml
Description (DE)
BARACLUDE Lös 0.05 mg/ml Fl 210 ml
Market launch
10/08/2006
Narcotic (BTM)
No

Available generics (4)

Entecavir-Mepha, Lactab
GTIN: 7680667090014
CHF 402.55
View
Entecavir-Mepha, Lactab
GTIN: 7680667090021
CHF 504.00
View
Entecavir Sandoz, Filmtabletten
GTIN: 7680664490022
CHF 402.55
View
Entecavir Sandoz, Filmtabletten
GTIN: 7680664490046
CHF 504.00
View